Open AccessA phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: Results from Cancer and Leukemia Group B Study 90006
Author(s) -
Joel Picus,
Susan Halabi,
W. Kevin Kelly,
Nicholas J. Vogelzang,
Young E. Whang,
Elizabeth Kaplan,
Walter M. Stadler,
Eric J. Small
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/rkbb-md51
Subject(s) - docetaxel , estramustine , medicine , bevacizumab , oncology , cancer , prostate cancer , leukemia , chemotherapy , prostate disease